Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2018
Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats through anti-inflammatory effectsShohei Tachibana, Masayuki Iyoda, Kei Matsumoto, et al.CEN Case Reports|May 1, 2019
Membranous nephropathy caused by rheumatoid arthritisAyana Iida, Yukihiro Wada, Junichi Hayashi, et al.Kidney & Blood Pressure Research|March 9, 2020
Therapeutic Potential of Thrombomodulin in Renal Fibrosis of Nephrotoxic Serum Nephritis in Wistar-Kyoto RatsNobuhiro Kanazawa, Masayuki Iyoda, Shohei Tachibana, et al.Clinical and Experimental Nephrology|September 29, 2005
Microscopic polyangiitis after silicone breast implantationMasayuki Iyoda, Jyun Ito, Hisako Nagai, et al.Clinical Rheumatology|December 21, 2007
Elderly onset systemic lupus erythematosus (SLE) presenting with disseminated intravascular coagulation (DIC)Masayuki Iyoda, Hiroki Suzuki, Eijin Ashikaga, et al.Letters in Applied Microbiology|March 24, 2024
In vitro investigation of the effects of Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 exopolysaccharides on tight junction damage caused by influenza virus infectionHiroki Ishikawa, Yoshihiro Kuno, Takehiro Yokoo, et al.Plos One|November 15, 2019
Serum uromodulin is associated with the severity of clinicopathological findings in ANCA-associated glomerulonephritisShohei Tachibana, Masayuki Iyoda, Taihei Suzuki, et al.American Journal of Physiology. Cell Physiology|July 2, 2025
NKT cell deficiency exacerbates adenine-induced renal fibrosis through enhanced Treg infiltration and TGF-β expressionYoshihiro Kuno, Hiroki Ishikawa, Ryuichi Nagashima, et al.Internal Medicine (Tokyo, Japan)|August 20, 2010
A case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and CA-125 levelsYoshihiro Kuno, Masayuki Iyoda, Yumie Aoshima, et al.Plos One|March 16, 2018
The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trialKen Iseri, Masayuki Iyoda, Makoto Watanabe, et al.Pageof 7